Effect of Sitagliptin on Progression of Coronary Intermediate Lesion

Clinical trial NCT02655757 · COMPLETED

Trial details

NCT number: NCT02655757
Sponsor: Li Bo
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Atherosclerosis Type 2 Diabetes Mellitus

Start date: 2015-12-01
Primary completion: 2017-02-02
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.